| 1 |
Ayob N, Muhammad Nawawi KN, Mohamad Nor MH, Raja Ali RA, Ahmad HF, Oon SF, Mohd Mokhtar N. The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2023;11. [PMID: 36831176 DOI: 10.3390/biomedicines11020640] [Reference Citation Analysis]
|
| 2 |
López-lluch G. Coenzyme Q as an Antiaging Strategy. Emerging Anti-Aging Strategies 2023. [DOI: 10.1007/978-981-19-7443-4_2] [Reference Citation Analysis]
|
| 3 |
Gudan A, Jamioł-Milc D, Hawryłkowicz V, Skonieczna-Żydecka K, Stachowska E. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression. Nutrients 2022;14. [PMID: 36558421 DOI: 10.3390/nu14245261] [Reference Citation Analysis]
|
| 4 |
Chiurazzi M, Cacciapuoti N, Di Lauro M, Nasti G, Ceparano M, Salomone E, Guida B, Lonardo MS. The Synergic Effect of a Nutraceutical Supplementation Associated to a Mediterranean Hypocaloric Diet in a Population of Overweight/Obese Adults with NAFLD. Nutrients 2022;14. [PMID: 36432436 DOI: 10.3390/nu14224750] [Reference Citation Analysis]
|
| 5 |
Esmaeili S. Effects of combined resistance and interval training in females with nonalcoholic fatty liver disease.. [DOI: 10.21203/rs.3.rs-2094137/v1] [Reference Citation Analysis]
|
| 6 |
Naseri K, Saadati S, Yari Z, Askari B, Mafi D, Hoseinian P, Asbaghi O, Hekmatdoost A, de Courten B. Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients 2022;14:3224. [PMID: 35956400 DOI: 10.3390/nu14153224] [Reference Citation Analysis]
|
| 7 |
Yun Y, Lee J. Alliin, capsaicin, and gingerol attenuate endoplasmic reticulum stress-induced hepatic steatosis in HepG2 cells and C57BL/6N mice. Journal of Functional Foods 2022;95:105186. [DOI: 10.1016/j.jff.2022.105186] [Reference Citation Analysis]
|
| 8 |
Jorquera G, Cubero FJ. Inflammaging, a Common Factor in the Development of Sarcopenia and Metabolic-Associated Liver Disease (MAFLD). Livers 2022;2:116-118. [DOI: 10.3390/livers2030010] [Reference Citation Analysis]
|
| 9 |
Hartleb M, Mastalerz-Migas A, Kowalski P, Okopień B, Popovic B, Proga K, Cywińska-Durczak B. Healthcare practitioners' diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey. Eur J Gastroenterol Hepatol 2022;34:426-34. [PMID: 34560694 DOI: 10.1097/MEG.0000000000002288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Doustmohammadian A, Clark CCT, Maadi M, Motamed N, Sobhrakhshankhah E, Ajdarkosh H, Mansourian MR, Esfandyari S, Hanjani NA, Nikkhoo M, Zamani F. Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS). Sci Rep 2022;12:2131. [PMID: 35136128 DOI: 10.1038/s41598-022-06035-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Du T, Fang Q, Zhang Z, Zhu C, Xu R, Chen G, Wang Y. Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway. Metabolites 2022;12:55. [PMID: 35050176 DOI: 10.3390/metabo12010055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Milton-Laskibar I, Marcos-Zambrano LJ, Gómez-Zorita S, Fernández-Quintela A, Carrillo de Santa Pau E, Martínez JA, Portillo MP. Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset. Nutrients 2021;13:1738. [PMID: 34065444 DOI: 10.3390/nu13051738] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 13 |
Gyorfi N, Odry A, Karadi Z, Odry P, Szakall T, Kuljic B, Toth A, Vizvari Z. Development of Bioimpedance-based Measuring Systems for Diagnosis of Non-alcoholic Fatty Liver Disease. 2021 IEEE 15th International Symposium on Applied Computational Intelligence and Informatics (SACI) 2021. [DOI: 10.1109/saci51354.2021.9465584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Słomko J, Zalewska M, Niemiro W, Kujawski S, Słupski M, Januszko-Giergielewicz B, Zawadka-Kunikowska M, Newton J, Hodges L, Kubica J, Zalewski P. Evidence-Based Aerobic Exercise Training in Metabolic-Associated Fatty Liver Disease: Systematic Review with Meta-Analysis. J Clin Med 2021;10:1659. [PMID: 33924482 DOI: 10.3390/jcm10081659] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Gaschinard M, Tetard C, Lamireau D, Chateil J, Le Bail B, Thibault H, Guimber D, Lamireau T, Enaud R. Découverte d’une stéatose hépatique chez l’enfant. Perfectionnement en Pédiatrie 2021;4:44-53. [DOI: 10.1016/j.perped.2021.01.004] [Reference Citation Analysis]
|
| 16 |
Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. Nutrients 2021;13:494. [PMID: 33546130 DOI: 10.3390/nu13020494] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 17 |
López-Lluch G. Coenzyme Q homeostasis in aging: Response to non-genetic interventions. Free Radic Biol Med 2021;164:285-302. [PMID: 33454314 DOI: 10.1016/j.freeradbiomed.2021.01.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
